FDA Drug recall D-1355-2014
Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only
- FDA Drug
- Class II
- terminated
- Published 2014-06-04
On 2014-06-04 the FDA classified a Class II recall of Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only by Wockhardt Usa, citing failed Dissolution Specifications: Failure of dissolution test observed at three month time point.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1355-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-04-10 |
| Published | 2014-06-04 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Wockhardt Usa |
| Distribution | US |
Product
Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Water view Blvd., Parsippany, NJ 07054, USA. NDC: 64679-736-02.
Reason
Failed Dissolution Specifications: Failure of dissolution test observed at three month time point.
Identifiers
| code_info | Lot #: LN11423, Expiry: 8/15/15 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1355-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.